CLSA ON INDUSIND BANK
Maintain Buy, Target `1130

Bank stays among our top picks in the banking sector
Core growth, buyout and capital raisings drive top line growth
Casa franchise is scaling-up; base rate transition manageable
Asset quality stable; RWA/total asset ratio stays high
Expect 28% profit CAGR over FY15-18

CS ON NAVKAR CORPORATION

CFS volumes have grown at 10.5% CAGR over FY13-15
Focus on export and hazardous cargo are key differentiators
Mgmt expects strong growth from Vapi ICD, logistics park
Vapi ICD is expected to start shortly on a road basis
Vapi ICD  would connect via rail from 3Q CY16
Management says rail competitive over short distance also

BOFA ML ON AUROBINDO PHARMA
Maintain Buy, Target `935

gAbilify is attractive opportunity; 17 approvals YTD FY16 
gAbilify will add $75mn sales over the next 12 months
Portfolio mix is evolving; injectable launches to ramp-up

UBS ON MOTHERSON SUMI
Cut target to `340 from `355, Maintain Buy
Expect earnings to double in 3 years even in downside case
Strong growth outlook across businesses and M&A upside
Maruti indicates that there is no policy to restrict a vendor to 70% of a business
Sharp market share losses in India unlikely